Exact Mass: 264.0626
Exact Mass Matches: 264.0626
Found 139 metabolites which its exact mass value is equals to given mass value 264.0626,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Sulfamerazine
Sulfamerazine is only found in individuals that have used or taken this drug.It is a sulfanilamide that is used as an antibacterial agent. [PubChem]Sulfamerazine is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthetase (dihydrofolate synthetase). Sulfamerazine is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BA - Sulfonamides J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
2',2'-Difluorodeoxyuridine
2,2-Difluorodeoxyuridine is a metabolite of gemcitabine. Gemcitabine is a nucleoside analog used as chemotherapy. It is marketed as Gemzar by Eli Lilly and Company. (Wikipedia)
Necatorine
Necatorine is found in mushrooms. Necatorine is an alkaloid from the mushroom Lactarius necator.
dapsone hydroxylamine
dapsone hydroxylamine is a metabolite of dapsone. Dapsone (diamino-diphenyl sulfone) is a medication most commonly used in combination with rifampicin and clofazimine as multidrug therapy (MDT) for the treatment of Mycobacterium leprae infections. It is also second-line treatment for prophylaxis (prevention) against Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii (formerly P. carinii) in HIV patients in whom CD4 counts are below 200/mm. (Wikipedia)
1-[(4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
Difluorodeoxyuridine
Ethanethioic acid, S-(2-(((2R)-2-(acetylamino)-3-mercapto-1-oxopropyl)amino)ethyl)ester
2,2-Difluoro-n-(2-hydroxyethyl)-3-(2-nitro-1h-imidazol-1-yl)propanamide
1-[(2R,4S,5S)-5-[Difluoro(hydroxy)methyl]-4-hydroxyoxolan-2-yl]pyrimidine-2,4-dione
3,3-Methylenebis(4-hydroxy-6-methyl-2H-pyran-2-one)
Acetic acid 2-oxo-5,6-dimethoxy-2H-1-benzopyran-7-yl ester
2,5-dihydroxy-3,8-dimethoxy-7-methylnaphtho-1,4-quinone|Nepenthone E
2-Propenoic acid, 3-[3,4-bis(acetyloxy)phenyl]-, (E)-
sulfamerazine
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BA - Sulfonamides J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides CONFIDENCE standard compound; INTERNAL_ID 1016
2,2-Difluorodeoxyuridine
CONFIDENCE standard compound; EAWAG_UCHEM_ID 2649 2′,2′-Difluorodeoxyuridine (dFdU) is the main metabolite of Gemcitabine (HY-17026). 2′,2′-Difluorodeoxyuridine causes a concentration- and schedule- dependent radiosensitising effect in vitro[1].
4-hydroxy-3-[(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-6-methylpyran-2-one
3,7,8-trihydroxy-3-methyl-1,4-dihydropyrano[4,3-b]chromen-10-one
4-hydroxy-3-[(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-6-methylpyran-2-one
4-hydroxy-3-[(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-6-methylpyran-2-one_major
3-(THIAZOL-2-YLCARBAMOYL)-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID
Methyl 4-amino-3-(4-methoxyphenyl)isothiazole-5-carboxylate
2-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)ISOINDOLINE-1,3-DIONE
4-(2-chloroacetyl)-1,5-dimethyl-2-phenyl-pyrazol-3-one
3-AMINO-3-[5-(2-CHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID AMIDE
3-AMINO-3-[5-(3-CHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID AMIDE
Methyl 2-amino-4-(3-methoxyphenyl)thiazole-5-carboxylate
METHYL 2-AMINO-4-(4-METHOXYPHENYL)THIAZOLE-5-CARBOXYLATE
Glycine, N-[2-[(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl ), disodium salt
2-(4-CHLOROPHENYL)-5-METHYL-3H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
5-(4,6-Dimethyl-pyrimidin-2-ylsulfanylmethyl)-furan-2-carboxylic acid
5-CHLORO-1-P-TOLYL-1H-PYRAZOLE-3-CARBOXYLICACIDETHYLESTER
Sulfaperin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
methyl 3-(2,4-diaminophenoxy)thiophene-2-carboxylate
Fluoro-N,N,N,N-tetramethylformamidinium hexafluorophosphate
2-(5-(TRIFLUOROMETHYL)-1H-INDOL-3-YL)ETHANAMINE HYDROCHLORIDE
ETHYL 1-(4-CHLOROPHENYL)-5-METHYL-1H-PYRAZOLE-3-CARBOXYLATE
methyl (E)-3-(4-methyl-1,3-thiazol-5-yl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate
1-[1-(PHENYLSULFONYL)-1H-PYRROL-3-YL]ETHAN-1-ONE OXIME
2-[METHYL-2-NITRO-4-(TRIFLUOROMETHYL)ANILINO]ETHAN-1-OL
4(3H)-Quinazolinone, 2-chloro-5-cyclobutyl-7-methoxy-
Urea,1-(8-hydroxy-2-methyl-4-oxo-3(4H)-quinazolinyl)-3-methyl-2-thio- (6CI)
1-(4-CHLOROPHENYL)-5-PROPYL-1H-PYRAZOLE-4-CARBOXYLIC ACID
5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)-5,6-dihydropyrimidin-4(3h)-one hydrochloride
5-(2,5-Dioxotetrahydrofuryl)-3-Methyl-3-Cyclohexene-1,2-Dicarboxylic Anhydride
2-amino-8-phenyl-7,9-dioxa-1-thia-3-azaspiro[4.5]dec-2-en-4-one
2-Amino-2-(6-phenyl-3-pyridyl)acetic Acid Hydrochloride
2-Amino-2-[4-(2-pyridyl)phenyl]acetic Acid Hydrochloride
2-(8-Hydroxy-6-methoxy-1-oxo-1H-isochromen-3-yl)propionic acid
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C1971 - Angiogenesis Activator Inhibitor
Ozagrel hydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D004791 - Enzyme Inhibitors
3,8,9,10-Tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione
5,6-Difluoro-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
1-[(2R,4S,5S)-5-[Difluoro(hydroxy)methyl]-4-hydroxyoxolan-2-yl]pyrimidine-2,4-dione
2-methoxy-N-methyl-N-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]acetamide
4-chloro-N-(4-ethylphenyl)-3-methyl-5-isoxazolecarboxamide
1,3-dimethyl-6-[(2E)-2-(thiophen-2-ylmethylidene)hydrazinyl]pyrimidine-2,4(1H,3H)-dione
1-[(4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
(3S)-3,7,8-trihydroxy-3-methyl-1,4-dihydropyrano[4,3-b]chromen-10-one
(5E)-4-Amino-5-[(3-ethoxy-4-hydroxyphenyl)methylidene]-1,3-thiazol-2-one
1,3-dimethyl-6-[2-(thiophen-2-ylmethylidene)hydrazinyl]pyrimidine-2,4-dione
2,2-Difluoro-2-deoxyuridine
A pyrimidine 2-deoxyribonucleoside that is uridine in which the hydroxy group at position 2 has been replaced by two fluoro substituents. It is a metabolite of the drug gemcitabine.
